Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy
暂无分享,去创建一个
T. Kasamatsu | K. Yonemori | C. Shimizu | Y. Fujiwara | T. Kamura | Koji Matsumoto | S. Nishio | H. Tanabe | N. Katsumata | T. Kouno | M. Ando